Light Mode
$0.0240 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0240, and at the day’s high of $0.0240
+0.00 (+0.00%) / 6M
Momentum, market sentiment, and recent alerts
SQZB reads n/a: price sits above one of the two key moving averages, the 12-month move is +4.3%.
No alerts for SQZB in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
SQZ Biotechnologies Co. is a clinical-stage biotechnology company, which engages in developing cell therapies for patients with cancer, infectious diseases, and other serious conditions. It operates through SQZ cell therapy platform, which uses membrane disruption to deliver material into cells. The company was founded by Robert S. Langer Jr., Klavis F. Jensen, Agustin Lopez Marquez, and Armon Sharei in March 2013 and is headquartered in Watertown, MA.
No peer group available for this symbol.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.